SIGA SIGA TECHNOLOGIES INC

Nasdaq Pharmaceutical Preparations DE CIK: 0001010086
AI RATING
SELL
88% Confidence

Investment Thesis

SIGA is experiencing severe operational distress with revenue declining 31.8% YoY while operating at substantial losses (-85.2% operating margin). Despite a strong balance sheet with $145.6M in cash, the company is burning cash operationally and generating negative returns, indicating fundamental business model challenges that require immediate restructuring to achieve viability.

Strengths

  • + Strong cash position of $145.6M provides financial runway for operations and strategic initiatives
  • + Robust liquidity ratios (Current: 3.25x, Quick: 2.38x) ensure near-term solvency and operational flexibility
  • + Conservative leverage (Debt/Equity: 0.52x) limits financial distress risk and provides debt capacity for refinancing

Risks

  • ! Sharp revenue decline of 31.8% YoY suggests lost contracts, market share erosion, or product demand collapse
  • ! Severe unprofitability (-85.2% operating margin, -$5.3M operating loss on $6.2M revenue) indicates unsustainable unit economics
  • ! Negative operating cash flow (-$8.7M) coupled with negative ROE (-2.3%) and ROA (-1.6%) demonstrates cash burn and value destruction

Key Metrics to Watch

Financial Metrics

Revenue
6.2M
Net Income
-3.5M
EPS (Diluted)
$-0.05
Free Cash Flow
-8.7M
Total Assets
219.4M
Cash
145.6M

Profitability Ratios

Gross Margin N/A
Operating Margin -85.2%
Net Margin -55.3%
ROE -2.3%
ROA -1.6%
FCF Margin -139.3%

Balance Sheet & Liquidity

Current Ratio
3.25x
Quick Ratio
2.38x
Debt/Equity
0.52x
Debt/Assets
30.9%
Interest Coverage
N/A
Long-term Debt
78.9M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-16T10:18:32.764392 | Data as of: 2026-03-31 | Powered by Claude AI